Clinical Trial Update: Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease [Phase 2, Phase 3]

View source ↗

Summary

This entry provides an update on a Phase 2/Phase 3 clinical trial evaluating the effect of spironolactone on electrolyte supplementation in preterm infants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Lung Disease

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: West Virginia University Healthcare | Conditions: Chronic Lung Disease, Bronchopulmonary Dysplasia | Phase 2, Phase 3 | Status: UNKNOWN